metricas
covid
Acta Otorrinolaringológica Española Disease control in unresectable laryngeal carcinoma cuniculatum using pembrolizu...
Journal Information
Vol. 76. Issue 5.
(September - October 2025)
Share
Download PDF
More article options
Vol. 76. Issue 5.
(September - October 2025)
Case study
Disease control in unresectable laryngeal carcinoma cuniculatum using pembrolizumab and chemotherapy: A case report
Uso de Pembrolizumab y quimioterapia para el control de la enfermedad en un carcinoma cuniculatum laríngeo irresecable: Reporte de caso
Natalia Arango Cabezasa, Rosa Delia Ramirez-Ruiza,b,c,d,
Corresponding author
rdramirez@clinic.cat

Corresponding author.
, Nuria Cuestab, Isabel Vilasecaa,b,c,d,e
a Otorhinolaryngology Department, Hospital Clínic, Barcelona, Spain
b Head Neck Cancer Unit, Hospital Clínic, Barcelona, Spain
c Department of Surgery and Medical-Surgical Specialties, Faculty of Medicine, University of Barcelona, Barcelona, Spain
d Head Neck Clínic, AGAUR 2021 SGR 01298, Barcelona, Spain
e Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (3)
Show moreShow less

Article

These are the options to access the full texts of the publication Acta Otorrinolaringológica Española
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Acta Otorrinolaringológica Española

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools